Arcus Biosciences (RCUS) Research & Development (2017 - 2025)
Historic Research & Development for Arcus Biosciences (RCUS) over the last 9 years, with Q3 2025 value amounting to $141.0 million.
- Arcus Biosciences' Research & Development rose 1463.41% to $141.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $503.0 million, marking a year-over-year increase of 1431.82%. This contributed to the annual value of $448.0 million for FY2024, which is 3176.47% up from last year.
- According to the latest figures from Q3 2025, Arcus Biosciences' Research & Development is $141.0 million, which was up 1463.41% from $139.0 million recorded in Q2 2025.
- In the past 5 years, Arcus Biosciences' Research & Development ranged from a high of $141.0 million in Q3 2025 and a low of $50.6 million during Q4 2021
- Over the past 5 years, Arcus Biosciences' median Research & Development value was $82.0 million (recorded in 2023), while the average stood at $91.3 million.
- Its Research & Development has fluctuated over the past 5 years, first soared by 18686.8% in 2021, then crashed by 811.45% in 2022.
- Over the past 5 years, Arcus Biosciences' Research & Development (Quarter) stood at $50.6 million in 2021, then soared by 58.14% to $80.0 million in 2022, then grew by 16.25% to $93.0 million in 2023, then increased by 8.6% to $101.0 million in 2024, then surged by 39.6% to $141.0 million in 2025.
- Its Research & Development was $141.0 million in Q3 2025, compared to $139.0 million in Q2 2025 and $122.0 million in Q1 2025.